Inflammasome as a New Therapeutic Target for Diabetic Complications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 10, Iss. 1, 2016-10 ,pp. : 56-62

Bentham Science Publishers

Access to resources Recommend Favorite

HDL - Cholesterol: The New Target for Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 2, 2010-06 ,pp. : 153-160

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy with Dendritic Cells as a Cancer Treatment: Perspectives and Therapeutic Potential

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 3, 2013-09 ,pp. : 226-232

Bentham Science Publishers

Access to resources Recommend Favorite

Spontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 10, Iss. 1, 2016-04 ,pp. : 34-39

Bentham Science Publishers

Access to resources Recommend Favorite

Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique

By  

Recent Patents on Drug Delivery & Formulation, Vol. 10, Iss. 2, 2016-08 ,pp. : 82-129

Bentham Science Publishers

Access to resources Recommend Favorite